BLOC1S1 Knockout A-549 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population of human A-549 lung adenocarcinoma cells with targeted disruption of the BLOC1S1 gene. This heterogeneous pool provides a versatile loss-of-function model for investigating BLOC-1 biology in intracellular trafficking and lysosome-related organelle biogenesis. Without clonal selection, the polyclonal format captures a range of mutations, suited for gene-dosage and pathway studies.
Derived from a 58-year-old Caucasian male lung adenocarcinoma, A-549 is an adherent epithelial cell line extensively employed in cancer biology, oncogenic signaling studies, and chemotherapeutic testing. Its well-characterized genetic background and ease of manipulation make it an optimal platform for generating knockout models. This cell line is particularly relevant for exploring the intersection of vesicle trafficking and tumorigenesis in lung adenocarcinoma.
BLOC1S1 encodes a critical BLOC-1 complex subunit that mediates protein sorting from endosomes to lysosome-related organelles. It forms a scaffold with DTNBP1, BLOC1S2, SNAPIN, PLDN, CNO, and MUTED, and coordinates with AP-3 and BLOC-2 for cargo delivery. Transcription factors TFEB and MITF, under mTOR regulation, control its expression. Downstream, LAMP1/2 trafficking, tyrosinase delivery, and PMEL processing depend on BLOC-1 function, impacting vesicle acidification and maturation.
In A-549 lung adenocarcinoma cells, BLOC1S1 knockout abrogates BLOC-1 complex formation, leading to defective endosomal sorting and lysosome-related organelle biogenesis. This dysfunction can influence autophagy dynamics and cisplatin sensitivity, providing a model to study how vesicle trafficking impacts chemoresistance. Owing to BLOC-1’s association with Hermansky-Pudlak syndrome and schizophrenia through dysbindin (DTNBP1), this line also facilitates research on epithelial trafficking pathologies.
Researchers can utilize this polyclonal population in immunofluorescence microscopy for LAMP1 distribution, LysoTracker imaging for lysosomal acidity, and autophagy flux assays to evaluate BLOC1S1’s role in autophagosome maturation. Co-immunoprecipitation with BLOC1S2 or SNAPIN probes complex integrity. Functional assays such as wound healing and cisplatin sensitivity link trafficking to migration and drug response. Combined with RT-qPCR and western blotting, these tools enable comprehensive studies of lysosome-related organelle biology in lung cancer. For additional product details, please contact Ascent Research.
